MTA1 promotes cell proliferation via DNA damage repair in epithelial ovarian cancer

Genetics and Molecular Research

Volumn 13, Issue 4, 2014, Pages 10269-10278

  Yang, Q Y ^a   Li, J H ^a   Wang, Q Y ^a   Wu, Y ^a   Qin, J L ^a   Cheng, J J ^a   Qiu, J ^a  

^a TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

Cell proliferation; DNA repair; Metastasis associated gene 1; Ovarian carcinoma

Indexed keywords

CHECKPOINT KINASE 1; CISPLATIN; HISTONE H2AX; REPLICATION FACTOR A; SMALL INTERFERING RNA; ANTINEOPLASTIC AGENT; DNA; HISTONE DEACETYLASE; MTA1 PROTEIN, HUMAN; REPRESSOR PROTEIN;

ARTICLE; CANCER GROWTH; CANCER RESISTANCE; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CELLULAR DISTRIBUTION; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFICACY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE; GENE FUNCTION; GENE SILENCING; GROWTH INHIBITION; HUMAN; HUMAN CELL; MTA1 GENE; OVARY CARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; S PHASE CELL CYCLE CHECKPOINT; TUMOR PROMOTION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; CELL CYCLE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; OVARY TUMOR; PATHOLOGY; RADIATION RESPONSE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; DNA REPAIR; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HUMANS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; REPRESSOR PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84915821879     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.December.4.21     Document Type: Article

References (22)

1. Bagheri-Yarmand R, Talukder AH, Wang RA, Vadlamudi RK, et al. (2004). Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis. Development 131: 3469-3479.
2. Cortés-Gutiérrez EI, Hernández-Garza F, García-Perez JO, Dávila-Rodríguez MI, et al. (2012). Evaluation of DNA single and double strand breaks in women with cervical neoplasia based on alkaline and neutral comet assay techniques. J. Biomed. Biotechnol. 2012: 385245.
3. Dannenmann C, Shabani N, Friese K, Jeschke U, et al. (2008). The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERbeta, and enhances expression of oncogenic cytokine GRO. Cancer Biol. Ther. 7: 1460-1467.
4. Faught W (2009). Cancer of the ovary: there is reason for optimism. J. Obstet. Gynaecol. Can 31: 297-302.
5. Hickson I, Zhao Y, Richardson CJ, Green SJ, et al. (2004). Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 64: 9152-9159.
6. Kelley MR and Fishel ML (2008). DNA repair proteins as molecular targets for cancer therapeutics. Anticancer Agents Med. Chem. 8: 417-425.
7. Lan L, Ui A, Nakajima S, Hatakeyama K, et al. (2010). The ACF1 complex is required for DNA double-strand break repair in human cells. Mol. Cell 40: 976-987.
8. Li DQ and Kumar R (2010). Mi-2/NuRD complex making inroads into DNA-damage response pathway. Cell Cycle 9: 2071-2079.
9. Li DQ, Ohshiro K, Reddy SD, Pakala SB, et al. (2009). E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1. Proc. Natl. Acad. Sci. U. S. A. 106: 17493-17498.
10. Li DQ, Pakala SB, Reddy SD, Ohshiro K, et al. (2010a). Revelation of p53-independent function of MTA1 in DNA damage response via modulation of the p21 WAF1-proliferating cell nuclear antigen pathway. J. Biol. Chem. 285: 10044-10052.
11. Li DQ, Ohshiro K, Khan MN and Kumar R (2010b). Requirement of MTA1 in ATR-mediated DNA damage checkpoint function. J. Biol. Chem. 285: 19802-19812.
12. Li DQ, Pakala SB, Nair SS, Eswaran J, et al. (2012). Metastasis-associated protein 1/nucleosome remodeling and histone deacetylase complex in cancer. Cancer Res. 72: 387-394.
13. Liu JS, Kuo SR and Melendy T (2006). DNA damage-induced RPA focalization is independent of gamma-H2AX and RPA hyper-phosphorylation. J. Cell Biochem. 99: 1452-1462.
14. Matsuo K, Eno ML, Im DD, Rosenshein NB, et al. (2010). Clinical relevance of extent of extreme drug resistance in epithelial ovarian carcinoma. Gynecol. Oncol. 116: 61-65.
15. Mazumdar A, Wang RA, Mishra SK, Adam L, et al. (2001). Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat. Cell Biol. 3: 30-37.
16. Niziolek-Kierecka M, Dreij K, Lundstedt S and Stenius U (2012). GammaH2AX, pChk1, and Wip1 as potential markers of persistent DNA damage derived from dibenzo[a, l]pyrene and PAH-containing extracts from contaminated soils. Chem. Res. Toxicol. 25: 862-872.
17. O'Connor MJ, Martin NM and Smith GC (2007). Targeted cancer therapies based on the inhibition of DNA strand break repair. Oncogene 26: 7816-7824.
18. Siegel R, Naishadham D and Jemal A (2012). Cancer statistics, 2012. CA Cancer J. Clin. 62: 10-29.
19. Toh Y and Nicolson GL (2009). The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications. Clin. Exp. Metastasis 26: 215-227.
20. Toh Y, Pencil SD and Nicolson GL (1994). A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J. Biol. Chem. 269: 22958-22963.
21. Yi S, Guangqi H and Guoli H (2003). The association of the expression of MTA1, nm23H1 with the invasion, metastasis of ovarian carcinoma. Chin. Med. Sci. J. 18: 87-92.
22. Zhu Y, Hu J, Hu Y and Liu W (2009). Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance. Cancer Treat. Ver. 35: 590-596.